跳至主要内容
临床试验/ISRCTN74137878
ISRCTN74137878
已完成
不适用

A study to evaluate the different levels of attention and VALence direction for erotic stimuli, in relation to genital and subjective sexual arousal in healthy female subjects and healthy female subjects with female sexual dysfunctio

Emotional Brain B.V. (The Netherlands)0 个研究点目标入组 120 人2007年8月23日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Female sexual dysfunction
发起方
Emotional Brain B.V. (The Netherlands)
入组人数
120
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2007年8月23日
结束日期
待定
最后更新
11年前
研究类型
Interventional

研究者

发起方
Emotional Brain B.V. (The Netherlands)

入排标准

入选标准

  • 40 Subjects must meet the following criteria:
  • 1\. Subjects must have a heterosexual orientation
  • 2\. Subjects must be between 21 and 65 years of age
  • 3\. Subjects with normal sexual functioning
  • 4\. Subjects must have signed the Informed Consent Form
  • 5\. Inclusion will be following the selection criteria including, but not limited to, a physical examination, gynaecological examination, medical history, vital signs, pregnancy test and Electrocardiogram (ECG)
  • 80 Subjects must meet the following criteria:
  • 1\. Subjects must have a heterosexual orientation
  • 2\. Subjects must be between 21 and 65 years of age
  • 3\. Subjects must have experienced low sexual arousal and/or low sexual desire for at least six months prior to study entry according to Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM IV) criteria. The diagnosis will be made by an experienced psychologist/sexologist

排除标准

  • Subjects will not be eligible for inclusion if one of the following criteria applies:
  • 1\. Use of oral contraception containing anti\-androgens (Like Diane 35 or Minerva)
  • 2\. Use of oral contraception containing 50 µg oestrogen or more
  • 3\. Pregnancy, or intention to become pregnant during this study (note: a serum or urine pregnancy test will be performed in all women prior to the administration of study medications)
  • 4\. A pelvic inflammatory disease or an untreated vaginal infection at screening
  • 5\. Lactating or subjects who have given birth in the previous six months
  • 6\. Previous prolapse and incontinence surgery affecting the vaginal wall
  • 7\. Women with other unexplained gynaecological complaints, such as abnormal uterine bleeding patterns;
  • 8\. History of endocrinological treatment or current endocrinological treatment (with the exception of the use oral contraceptives and of fertility\-promoting treatment)
  • 9\. History of neurological treatment or current neurological treatment

结局指标

主要结局

未指定

相似试验